LIEN/PLUMBUM ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Lien/Plumbum, liquid dilution for injection. Indications: In accordance with anthroposophical knowledge of man and nature. These include: Harmonization of the catabolizing and demarcating function of the spleen, e.g., adjunctive treatment for pathologically enlarged spleen (splenomegaly), polycythemia, leukemia, plasma cell tumor (plasmacytoma), bone metastases.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Lien/Plumbum, liquid dilution for injection

Composition:
1 ampoule contains: Lien bovis Gl Dil. D5 0.1 g (HAB, Vs. 41a), Plumbum metallicum Dil. D29 aquos. 0.1 g. Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Indications:
According to anthroposophical understanding of man and nature. This includes: Harmonization of the catabolic and delimiting function of the spleen, e.g., as an adjunct treatment for pathological enlargement of the spleen (splenomegaly), polycythemia, leukemia, plasma cell tumors (plasmocytoma), and bone metastases.

Contraindications:
Do not use in cases of hypersensitivity to animal protein.

Precautions for use and warnings:
There is insufficient documented experience with the use of this medicine in children. It should therefore not be used in children under 12 years of age.

Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously twice a week to once daily.

Duration of use:
The duration of treatment for chronic illnesses requires consultation with a doctor.

Side effects:
None known.

Contents:
10 x 1 ml

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalogue
as of: 04/2025

Indications: According to anthroposophical understanding of man and nature. These include: Harmonization of the catabolizing and delimiting functions of the spleen, e.g., accompanying treatment for pathological enlargement of the spleen (splenomegaly), polycythemia, leukemia, plasma cell tumors (plasmocytoma), and bone metastases.